| MeSH term | MeSH ID | Detail |
|---|---|---|
| Weight Loss | D015431 | 56 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
| Szulc P et al. | Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21565793 |
| Zhang M et al. | EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. | 2011 | J. Bone Miner. Res. | pmid:20939055 |
| Millard SM et al. | Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation. | 2011 | J. Bone Miner. Res. | pmid:20939063 |
| Zhang Y et al. | Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. | 2011 | PLoS ONE | pmid:21897843 |
| Tanaka H et al. | Expression of RANKL/OPG during bone remodeling in vivo. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21771583 |
| Meulman T et al. | Impact of Porphyromonas gingivalis inoculation on ligature-induced alveolar bone loss. A pilot study in rats. | 2011 | J. Periodont. Res. | pmid:21726226 |
| Yang L et al. | Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. | 2011 | Chin. Med. J. | pmid:22088466 |
| Reinhard H et al. | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. | 2011 | Cardiovasc Diabetol | pmid:21801376 |
| Jabbar S et al. | Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. | 2011 | J. Periodont. Res. | pmid:20731767 |
| Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
| Sheng L et al. | [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21812275 |
| Yang XY et al. | [Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21868322 |
| Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
| Guo HL et al. | [Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. | 2011 | Zhongguo Gu Shang | pmid:21870401 |
| McGrath EE | OPG/RANKL/RANK pathway as a therapeutic target in cancer. | 2011 | J Thorac Oncol | pmid:21849854 |
| Findlay DM and Atkins GJ | Relationship between serum RANKL and RANKL in bone. | 2011 | Osteoporos Int | pmid:21850548 |
| Harada S and Takahashi N | [Control of bone resorption by RANKL-RANK system]. | 2011 | Clin Calcium | pmid:21814016 |
| Nakamura M and Udagawa N | [Osteoporosis and RANKL signal]. | 2011 | Clin Calcium | pmid:21814019 |
| Christoforidis A et al. | Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. | 2011 | Haemophilia | pmid:20825502 |
| Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
| Embree M et al. | Role of subchondral bone during early-stage experimental TMJ osteoarthritis. | 2011 | J. Dent. Res. | pmid:21917603 |
| Hope S et al. | Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. | 2011 | J Psychiatr Res | pmid:21889167 |
| Shin M et al. | The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. | 2011 | Carcinogenesis | pmid:21890459 |
| Grigoropoulou P et al. | The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. | 2011 | Curr. Med. Chem. | pmid:21919846 |
| Riancho JA and Delgado-Calle J | [Osteoblast-osteoclast interaction mechanisms]. | 2011 | Reumatol Clin | pmid:21924211 |
| Peng S et al. | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. | 2011 | Bone | pmid:21925296 |
| Fan R et al. | Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells. | 2011 | Chin. Med. J. | pmid:21933620 |
| Osorio A et al. | Mineral-bone metabolism markers in young hemodialysis patients. | 2011 | Clin. Biochem. | pmid:21933667 |
| Witasp A et al. | Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. | 2011 | Eur. J. Clin. Invest. | pmid:21128937 |
| Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
| Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
| Durual S et al. | Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. | 2011 | Clin Oral Implants Res | pmid:21087318 |
| Fradet A et al. | Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. | 2011 | Cancer Res. | pmid:21734015 |
| Ashley DT et al. | Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. | 2011 | Metab. Clin. Exp. | pmid:21087777 |
| Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
| Tekkesin MS et al. | The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. | 2011 | Head Neck Pathol | pmid:21643971 |
| Jiang JQ et al. | Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. | 2011 | Nephrology (Carlton) | pmid:21649792 |
| Choi EM | Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. | 2011 | Int. Immunopharmacol. | pmid:21621646 |
| Ueland T et al. | Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. | 2011 | J. Intern. Med. | pmid:21623962 |
| Wheater G et al. | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. | 2011 | Osteoporos Int | pmid:21625887 |
| Karadag-Saygi E et al. | The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | 2011 | Gynecol. Endocrinol. | pmid:21627558 |
| Taylor R et al. | Osteoclast formation and function in pigmented villonodular synovitis. | 2011 | J. Pathol. | pmid:21706481 |
| Conaway HH et al. | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. | 2011 | J. Biol. Chem. | pmid:21715325 |
| Colombini A et al. | Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. | 2011 | Int Orthop | pmid:20623281 |
| Kanayama K et al. | Osteoclast and osteoblast activities on carbonate apatite plates in cell cultures. | 2011 | J Biomater Appl | pmid:20624844 |
| Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
| Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
| Ikeda K et al. | Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. | 2011 | FEBS Lett. | pmid:21439958 |
| Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
| Katz J et al. | Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. | 2011 | Int J Oral Maxillofac Surg | pmid:21396799 |
| Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
| Di Bartolo BA et al. | Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. | 2011 | Cardiovasc. Res. | pmid:21447702 |
| Ho TY et al. | Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. | 2011 | Bone | pmid:21419242 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
| Vidal C et al. | Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. | 2011 | J. Mol. Endocrinol. | pmid:21994215 |
| Hemingway F et al. | In vitro generation of mature human osteoclasts. | 2011 | Calcif. Tissue Int. | pmid:21960377 |
| Dimitriadis K et al. | Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. | 2011 | Int. J. Cardiol. | pmid:21975354 |
| Yao Y et al. | Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. | 2011 | J. Oral Maxillofac. Surg. | pmid:22018252 |
| Brown TT et al. | Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. | 2011 | Antivir. Ther. (Lond.) | pmid:22024522 |
| Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
| Yener S et al. | Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? | 2011 | J. Endocrinol. Invest. | pmid:20530985 |
| de Souza JA et al. | Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. | 2011 | Arch. Oral Biol. | pmid:21511249 |
| Claro T et al. | Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. | 2011 | PLoS ONE | pmid:21525984 |
| Giro G et al. | Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. | 2011 | J. Oral Maxillofac. Surg. | pmid:21530046 |
| Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
| Naot D et al. | Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. | 2011 | Bone | pmid:21515435 |
| Aydin H et al. | Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. | 2011 | Minerva Endocrinol. | pmid:21519319 |
| Altinova AE et al. | Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. | 2011 | Scand. J. Clin. Lab. Invest. | pmid:21486111 |
| Mercatali L et al. | Bone metastases detection by circulating biomarkers: OPG and RANK-L. | 2011 | Int. J. Oncol. | pmid:21491082 |
| Stein SH et al. | Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | 2011 | J. Periodont. Res. | pmid:21463327 |
| Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
| Pepene CE et al. | Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. | 2011 | Eur. J. Endocrinol. | pmid:20974706 |
| Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
| Sipos W et al. | OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers. | 2011 | Horm. Metab. Res. | pmid:22161252 |
| Akinci B et al. | Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. | 2011 | Diabetes Res. Clin. Pract. | pmid:20970873 |
| Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
| Rauch A et al. | An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. | 2011 | FASEB J. | pmid:21233489 |
| Ueland T et al. | Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. | 2011 | Circ Heart Fail | pmid:21216833 |
| Tang T et al. | Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. | 2011 | Biomed Mater | pmid:21205994 |
| Attia EA et al. | Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. | 2011 | Int. J. Dermatol. | pmid:21182499 |
| Sun Z and Tee BC | Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. | 2011 | Anat Rec (Hoboken) | pmid:21157918 |
| Cannon JG et al. | Follicle-stimulating hormone promotes RANK expression on human monocytes. | 2011 | Cytokine | pmid:21159522 |
| Choe JY et al. | Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. | 2011 | J. Rheumatol. | pmid:21159831 |
| Mahoney DJ et al. | TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. | 2011 | Arthritis Rheum. | pmid:21162099 |
| Preshaw PM and Taylor JJ | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? | 2011 | J. Clin. Periodontol. | pmid:21323705 |
| Basu R et al. | Effects of physiological variations in circulating insulin levels on bone turnover in humans. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21325461 |
| Kamiya N et al. | Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. | 2011 | Int. J. Clin. Oncol. | pmid:21327451 |
| Eslami B et al. | Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. | 2011 | Calcif. Tissue Int. | pmid:21327765 |
| Jørgensen L et al. | Serum osteoprotegerin levels are related to height loss: the Tromsø Study. | 2011 | Eur. J. Epidemiol. | pmid:21331661 |
| Yuan H et al. | Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. | 2011 | J. Clin. Periodontol. | pmid:22092474 |
| Feng Z et al. | An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. | 2011 | Int J Mol Sci | pmid:21731457 |
| Mai QG et al. | Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. | 2011 | J. Cell. Biochem. | pmid:21618594 |
| Garcia VG et al. | Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. | 2011 | J. Clin. Periodontol. | pmid:22092666 |
| Kornak U | Animal models with pathological mineralization phenotypes. | 2011 | Joint Bone Spine | pmid:21550285 |
| Santini D et al. | Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. | 2011 | PLoS ONE | pmid:21559440 |
| Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
| Mariúba MV et al. | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. | 2011 | Braz. J. Med. Biol. Res. | pmid:21584440 |
| Tang Y et al. | Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. | 2011 | J Endod | pmid:22099899 |